Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Outlook Therapeutics Inc.
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-06-21
Purchase
2022-06-23
5:08 pm
Outlook Therapeutics Inc. OTLK Dagnon Terry
Chief Operating Officer
10,000 $1.05 $10,500 1,173,058
(Direct)
View
2022-06-21
Purchase
2022-06-23
5:07 pm
Outlook Therapeutics Inc. OTLK TRENARY C RUSSELL III
CEO
19,925 $1.06 $21,121 54,925
(Direct)
View
2022-03-01
Purchase
2022-03-03
5:30 pm
Outlook Therapeutics Inc. OTLK HILZINGER KURT J
Director
27,708 $1.69 $46,827 273,117
(Direct)
View
2022-02-24
Purchase
2022-02-28
5:57 pm
Outlook Therapeutics Inc. OTLK HILZINGER KURT J
Director
47,160 $1.4778 $69,694 245,409
(Direct)
View
2022-02-22
Purchase
2022-02-23
5:42 pm
Outlook Therapeutics Inc. OTLK HILZINGER KURT J
Director
175,132 $1.4673 $256,970 198,249
(Direct)
View
2021-12-06
Purchase
2021-12-06
5:27 pm
Outlook Therapeutics Inc. OTLK TRENARY C RUSSELL III
CEO
25,000 $1.39 $34,750 35,000
(Direct)
View
2021-12-06
Purchase
2021-12-06
5:26 pm
Outlook Therapeutics Inc. OTLK Dagnon Terry
Chief Operating Officer
25,201 $1.38 $34,777 1,163,058
(Direct)
View
2021-12-03
Purchase
2021-12-06
5:25 pm
Outlook Therapeutics Inc. OTLK Evanson Jeff
Chief Commercial Officer
35,200 $1.34 $47,168 1,177,130
(Direct)
View
2021-12-03
Purchase
2021-12-03
4:32 pm
Outlook Therapeutics Inc. OTLK Dagnon Terry
Chief Operating Officer
10,000 $1.42 $14,200 1,137,857
(Direct)
View
2021-12-02
Purchase
2021-12-02
5:09 pm
Outlook Therapeutics Inc. OTLK Haddadin Yezan Munther
Director
10,000 $1.39 $13,900 30,000
(Direct)
View
2021-12-02
Purchase
2021-12-02
5:08 pm
Outlook Therapeutics Inc. OTLK Sukhtian Faisal Ghiath
Director
18,000 $1.4 $25,200 38,000
(Direct)
View
2021-12-02
Purchase
2021-12-02
5:07 pm
Outlook Therapeutics Inc. OTLK TRENARY C RUSSELL III
CEO
10,000 $1.4 $14,000 10,000
(Direct)
View
2021-11-29
Purchase
2021-12-01
7:32 pm
Outlook Therapeutics Inc. OTLK Sukhtian Ghiath M.
GMS Ventures & Investments
Director
10% Owner
16,000,000 $1.25 $20,000,000 78,799,315
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-08-11
Option Award
2022-08-15
5:16 pm
N/A
2032-08-11
Outlook Therapeutics Inc. OTLK Haller Julia A
Director
25,000 $0 25,000
(Direct)
View
2022-04-21(A)
Other
2022-07-07
5:27 pm
N/A
N/A
Outlook Therapeutics Inc. OTLK Sukhtian Ghiath M.
GMS Ventures & Investments
Director
10% Owner
27,982,529 $0 83,799,315
(Indirect)
View
2022-04-21
Other
2022-04-22
4:38 pm
N/A
N/A
Outlook Therapeutics Inc. OTLK Sukhtian Faisal Ghiath
GMS Ventures & Investments
Director
10% Owner
27,982,529 $0 83,799,315
(Indirect)
View
2022-04-21
Other
2022-04-22
4:33 pm
N/A
N/A
Outlook Therapeutics Inc. OTLK BioLexis Pte Ltd.
10% Owner
27,982,529 $0 50,965,058
(Direct)
View
2022-03-31
Option Award
2022-04-04
6:47 pm
N/A
2031-12-21
Outlook Therapeutics Inc. OTLK Evanson Jeff
Chief Commercial Officer
100,000 $0 100,000
(Direct)
View
2022-03-31
Option Award
2022-04-04
6:46 pm
N/A
2031-12-21
Outlook Therapeutics Inc. OTLK Dagnon Terry
Chief Operating Officer
100,000 $0 100,000
(Direct)
View
2022-03-31
Option Award
2022-04-04
6:44 pm
N/A
2031-12-21
Outlook Therapeutics Inc. OTLK TRENARY C RUSSELL III
CEO
500,000 $0 500,000
(Direct)
View
2022-03-23
Option Award
2022-03-24
5:42 pm
N/A
2032-03-23
Outlook Therapeutics Inc. OTLK Gangolli Julian S
Director
21,878 $0 21,878
(Direct)
View
2022-03-23
Option Award
2022-03-24
5:41 pm
N/A
2032-03-23
Outlook Therapeutics Inc. OTLK HILZINGER KURT J
Director
21,878 $0 21,878
(Direct)
View
2022-03-23
Option Award
2022-03-24
5:40 pm
N/A
2032-03-23
Outlook Therapeutics Inc. OTLK Sukhtian Faisal Ghiath
Director
21,878 $0 21,878
(Direct)
View
2022-03-23
Option Award
2022-03-24
5:39 pm
N/A
2032-03-23
Outlook Therapeutics Inc. OTLK Haddadin Yezan Munther
Director
21,878 $0 21,878
(Direct)
View
2022-03-23
Option Award
2022-03-24
5:38 pm
N/A
2032-03-23
Outlook Therapeutics Inc. OTLK Auffarth Gerd
Director
21,878 $0 21,878
(Direct)
View
2022-03-23
Option Award
2022-03-24
5:37 pm
N/A
2032-03-23
Outlook Therapeutics Inc. OTLK Huang Andong
Director
21,878 $0 21,878
(Direct)
View
2022-03-23
Option Award
2022-03-24
5:36 pm
N/A
2032-03-23
Outlook Therapeutics Inc. OTLK THURMAN RANDY H
Director
81,878 $0 81,878
(Direct)
View
2022-02-01
Other
2022-02-01
5:09 pm
N/A
N/A
Outlook Therapeutics Inc. OTLK Pillai Arun Kumar
Director
10% Owner
2,500,000 $1.25 25,482,529
(Indirect)
View
2022-02-01
Other
2022-02-01
5:05 pm
N/A
N/A
Outlook Therapeutics Inc. OTLK Sukhtian Ghiath M.
GMS Ventures & Investments
Director
10% Owner
2,500,000 $1.25 58,316,786
(Indirect)
View
2021-12-21
Option Award
2021-12-23
5:32 pm
N/A
2031-12-21
Outlook Therapeutics Inc. OTLK Evanson Jeff
Chief Commercial Officer
800,000 $0 800,000
(Direct)
View
2021-12-21
Option Award
2021-12-23
5:31 pm
N/A
2031-12-21
Outlook Therapeutics Inc. OTLK Dagnon Terry
Chief Operating Officer
800,000 $0 800,000
(Direct)
View
2021-10-05
Option Award
2021-10-07
5:09 pm
N/A
2031-10-05
Outlook Therapeutics Inc. OTLK Huang Andong
Director
22,950 $0 22,950
(Direct)
View
2021-10-05
Option Award
2021-10-07
5:08 pm
N/A
2031-10-05
Outlook Therapeutics Inc. OTLK Auffarth Gerd
Director
25,245 $0 25,245
(Direct)
View
2021-10-05
Option Award
2021-10-07
5:07 pm
N/A
2031-10-05
Outlook Therapeutics Inc. OTLK Gangolli Julian S
Director
44,466 $0 44,466
(Direct)
View
2021-10-05
Option Award
2021-10-07
5:06 pm
N/A
2031-10-05
Outlook Therapeutics Inc. OTLK Haddadin Yezan Munther
Director
47,335 $0 47,335
(Direct)
View
2021-10-05
Option Award
2021-10-07
5:05 pm
N/A
2031-10-05
Outlook Therapeutics Inc. OTLK Sukhtian Faisal Ghiath
Director
44,753 $0 44,753
(Direct)
View
2021-10-05
Option Award
2021-10-07
5:03 pm
N/A
2031-10-05
Outlook Therapeutics Inc. OTLK HILZINGER KURT J
Director
34,425 $0 34,425
(Direct)
View
2021-07-06
Option Award
2021-07-08
5:26 pm
N/A
2031-07-06
Outlook Therapeutics Inc. OTLK TRENARY C RUSSELL III
CEO
4,000,000 $0 4,000,000
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, 3, 4, Next